日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Artificial Intelligence and Prostate–Breast Cancer Biology: Recent Advances in Treatments and Perspectives — A Comprehensive Review

人工智能与前列腺癌-乳腺癌生物学:治疗和展望的最新进展——一项综合综述

Pashtan, Itai M; Recht, Abram; Ancukiewicz, Marek; Brachtel, Elena; Abi-Raad, Rita F; D'Alessandro, Helen A; Levy, Antonin; Wo, Jennifer Y; Hirsch, Ariel E; Kachnic, Lisa A; Goldberg, Saveli; Specht, Michelle; Gadd, Michelle; Smith, Barbara L; Powell, Simon N; Taghian, Alphonse G; Ouma, Russell B O; Ngari, Silas M; Kibet, Joshua K

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study

Balstilimab 和 Zalifrelimab 联合双重 PD-1 和 CTLA-4 检查点阻断作为晚期宫颈癌二线治疗:一项开放标签 II 期研究

O'Malley, David M; Neffa, Maryna; Monk, Bradley J; Melkadze, Tamar; Huang, Marilyn; Kryzhanivska, Anna; Bulat, Iurie; Meniawy, Tarek M; Bagameri, Andrea; Wang, Edward W; Doger de Speville Uribe, Bernard; Hegg, Roberto; Ortuzar Feliu, Waldo; Ancukiewicz, Marek; Lugowska, Iwona

Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients

肝细胞癌患者肝切除或肝移植术后复发的潜在循环生物标志物

Duda, Dan G; Dima, Simona O; Cucu, Dana; Sorop, Andrei; Klein, Sebastian; Ancukiewicz, Marek; Kitahara, Shuji; Iacob, Speranta; Bacalbasa, Nicolae; Tomescu, Dana; Herlea, Vlad; Tanase, Cristiana; Croitoru, Adina; Popescu, Irinel

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

肥胖通过上调IL-6和潜在的FGF-2,促进乳腺癌对VEGF抑制剂的耐药性。

Incio, Joao; Ligibel, Jennifer A; McManus, Daniel T; Suboj, Priya; Jung, Keehoon; Kawaguchi, Kosuke; Pinter, Matthias; Babykutty, Suboj; Chin, Shan M; Vardam, Trupti D; Huang, Yuhui; Rahbari, Nuh N; Roberge, Sylvie; Wang, Dannie; Gomes-Santos, Igor L; Puchner, Stefan B; Schlett, Christopher L; Hoffmman, Udo; Ancukiewicz, Marek; Tolaney, Sara M; Krop, Ian E; Duda, Dan G; Boucher, Yves; Fukumura, Dai; Jain, Rakesh K

Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease

标准分割外照射放疗联合或不联合术中放疗治疗局部复发性直肠癌:局部治疗在远处转移死亡风险高的患者中的作用

Kishan, Amar U; Voog, Justin C; Wiseman, Jonathan; Cook, Ryan R; Ancukiewicz, Marek; Lee, Percy; Ryan, David P; Clark, Jeffrey W; Berger, David L; Cusack, James C; Wo, Jennifer Y; Hong, Theodore S

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade

前列腺癌根治性治疗后的长期生活质量:治疗后第二个十年患者报告的结果

Jang, Joanne W; Drumm, Michael R; Efstathiou, Jason A; Paly, Jonathan J; Niemierko, Andrzej; Ancukiewicz, Marek; Talcott, James A; Clark, Jack A; Zietman, Anthony L

Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation

心脏和炎症生物标志物与接受辐射的心脏或肺脏体积无关

Kuo, Angera H; Ancukiewicz, Marek; Kozak, Kevin R; Yock, Torunn I; Padera, Timothy P

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.

一项针对可切除胰腺导管腺癌的术前短期放化疗(质子束疗法和卡培他滨)后早期手术的 1/2 期生物标志物研究

Hong Theodore S, Ryan David P, Borger Darrell R, Blaszkowsky Lawrence S, Yeap Beow Y, Ancukiewicz Marek, Deshpande Vikram, Shinagare Shweta, Wo Jennifer Y, Boucher Yves, Wadlow Raymond C, Kwak Eunice L, Allen Jill N, Clark Jeffrey W, Zhu Andrew X, Ferrone Cristina R, Mamon Harvey J, Adams Judith, Winrich Barbara, Grillo Tarin, Jain Rakesh K, DeLaney Thomas F, Fernandez-del Castillo Carlos, Duda Dan G

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy.

肝细胞癌的磁共振成像生物标志物:与舒尼替尼治疗后的反应和循环生物标志物的关联

Sahani Dushyant V, Jiang Tao, Hayano Koichi, Duda Dan G, Catalano Onofrio A, Ancukiewicz Marek, Jain Rakesh K, Zhu Andrew X

Efficacy, safety, pharmacokinetics, and biomarkers of cediranib monotherapy in advanced hepatocellular carcinoma: a phase II study.

西地尼布单药治疗晚期肝细胞癌的疗效、安全性、药代动力学和生物标志物:一项 II 期研究

Zhu Andrew X, Ancukiewicz Marek, Supko Jeffrey G, Sahani Dushyant V, Blaszkowsky Lawrence S, Meyerhardt Jeffrey A, Abrams Thomas A, McCleary Nadine Jackson, Bhargava Pankaj, Muzikansky Alona, Sheehan Susan, Regan Eileen, Vasudev Eamala, Knowles Michelle, Fuchs Charles S, Ryan David P, Jain Rakesh K, Duda Dan G